Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.18
Bid: 54.40
Ask: 54.44
Change: 0.12 (0.22%)
Spread: 0.04 (0.074%)
Open: 53.96
High: 54.42
Low: 53.30
Prev. Close: 54.06
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Final Terms

5 Jan 2024 13:50

RNS Number : 8310Y
Lloyds Banking Group PLC
05 January 2024

5 January 2024

Publication of Final Terms

The following Final Terms are available for viewing:

Final Terms dated 4 January 2024, for the EUR 500,000,000 4.375 per cent. Fixed Rate Reset Dated Subordinated Notes due 2034 (the "Notes") issued by Lloyds Banking Group plc pursuant to the base prospectus dated 30 June 2023 as supplemented by the supplementary prospectuses dated 26 July 2023 and 25 October 2023 (together, the "Prospectus") in connection with the £25,000,000,000 Euro Medium Term Note Programme established by Lloyds Banking Group plc.

The Final Terms for the Notes contain the final terms of the Notes. The Final Terms of the Notes must be read in conjunction with the Prospectus, which constitutes a base prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended).

To view the full documents, please paste the following URL into the address bar of your browser.

http://www.rns-pdf.londonstockexchange.com/rns/8310Y_1-2024-1-5.pdf

A copy of the Final Terms and the Prospectus have been submitted to the National Storage Mechanism and will shortly be available for inspection at: http://www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Investor Relations:

Douglas Radcliffe

Group Investor Relations Director

Tel: +44 20 7356 1571

Email: douglas.radcliffe@lloydsbanking.com

Group Corporate Affairs:

Matt Smith

Head of Media Relations

Tel: +44 (0) 7788 352 487

Email: matt.smith@lloydsbanking.com

Lloyds Banking Group plc

Registered Office

The MoundEdinburgh EH1 1YZ

Disclaimer - Intended Addressees

Please note that the information contained in the Final Terms and the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms or the Prospectus is not addressed. Prior to relying on the information contained in the Final Terms or the Prospectus, you must ascertain from the Final Terms and/or the Prospectus whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

EU MiFID II / UK MiFIR (Product Governance) - professionals / ECPs-only / No EU or UK PRIIPs KID - Manufacturer target market (EU MiFID II product governance and UK MiFIR product governance) is eligible counterparties and professional clients only (all distribution channels). No EU PRIIPs or UK PRIIPs key information document (KID) has been prepared as the Notes are not available to retail in the EEA or in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
PFTBDGDBCSGDGSU
Date   Source Headline
8th Mar 20224:10 pmRNS2021 Annual Report and Accounts
8th Mar 20222:34 pmRNSDirector/PDMR Shareholding
7th Mar 20225:48 pmRNSTransaction in Own Shares
7th Mar 20225:44 pmRNSTransaction in Own Shares
4th Mar 20225:12 pmRNSTransaction in Own Shares
3rd Mar 20225:39 pmRNSTransaction in Own Shares
2nd Mar 20225:40 pmRNSTransaction in Own Shares
2nd Mar 202212:52 pmRNSPublication of a Supplementary Prospectus
1st Mar 20226:01 pmRNSTransaction in Own Shares
1st Mar 20222:00 pmRNSDirector/PDMR Shareholding
1st Mar 20227:00 amRNS2021 Form 20F Filed
28th Feb 20225:39 pmRNSTransaction in Own Shares
28th Feb 20224:02 pmRNSTotal Voting Rights
25th Feb 20226:23 pmRNSTransaction in Own Shares
25th Feb 20221:00 pmRNSBlock Listing of Shares
25th Feb 20227:05 amRNSShare Buyback Programme Commences
24th Feb 20227:00 amRNS2021 Full Year Results
24th Feb 20227:00 amRNS2021 Annual Report and Accounts
18th Feb 20222:23 pmRNSNotice of Redemption
10th Feb 20222:00 pmRNSDirector/PDMR Shareholding
31st Jan 20222:28 pmRNSTotal Voting Rights
13th Jan 20227:00 amRNSPublication of Final Terms Replacement
12th Jan 20225:54 pmRNSPublication of Final Terms
11th Jan 20222:00 pmRNSDirector/PDMR Shareholding
4th Jan 20222:00 pmRNSBlock listing Interim Review
4th Jan 20229:46 amRNSNotice of Regulatory and Capital Event Redemptions
31st Dec 202111:00 amRNSTotal Voting Rights
17th Dec 20212:00 pmRNSDirector/PDMR Shareholding
17th Dec 20212:00 pmRNSBlock Listing of Shares
13th Dec 20216:04 pmRNSBank of England Stress Test Passed
10th Dec 20213:00 pmRNSDirector/PDMR Shareholding
10th Dec 202111:28 amRNSExchange Offer Final Results
10th Dec 202111:28 amRNSTender Offer Final Results
7th Dec 20214:08 pmRNSExchange Offer Pricing Terms
30th Nov 20212:00 pmRNSTotal Voting Rights
22nd Nov 202111:02 amRNSTender Offer First Results
11th Nov 20212:00 pmRNSDirector/PDMR Shareholding
10th Nov 20213:53 pmRNSCapital Securities Update and Exchange Offer
10th Nov 20213:53 pmRNSCapital Securities Update and Tender Offer
29th Oct 20212:00 pmRNSTotal Voting Rights
28th Oct 202112:49 pmRNS2021 Q3 Interim Management Statement
28th Oct 202112:41 pmRNSPublication of Supplementary Prospectus
28th Oct 20217:00 amRNS2021 Q3 Interim Management Statement
12th Oct 20212:33 pmRNSDirector/PDMR Shareholding
30th Sep 20212:00 pmRNSTotal Voting Rights
24th Sep 20211:19 pmRNSDirector/PDMR Shareholding
23rd Sep 20219:00 amRNSDirectorate Change
22nd Sep 20212:18 pmRNSDirector/PDMR Shareholding
21st Sep 20214:10 pmRNSDirector/PDMR Shareholding
17th Sep 20214:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.